AR016920A1 - FORMULACIoN DE 8A-AZALIDAS uTIL PARA EL TRATAMIENTO O PREVENCIoN DE UNA INFECCION ENTÉRICA O RESPIRATORIA BACTERIANA - Google Patents

FORMULACIoN DE 8A-AZALIDAS uTIL PARA EL TRATAMIENTO O PREVENCIoN DE UNA INFECCION ENTÉRICA O RESPIRATORIA BACTERIANA

Info

Publication number
AR016920A1
AR016920A1 ARP980104488A ARP980104488A AR016920A1 AR 016920 A1 AR016920 A1 AR 016920A1 AR P980104488 A ARP980104488 A AR P980104488A AR P980104488 A ARP980104488 A AR P980104488A AR 016920 A1 AR016920 A1 AR 016920A1
Authority
AR
Argentina
Prior art keywords
prevention
treatment
useful
azalides
formulation
Prior art date
Application number
ARP980104488A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9806029.6A external-priority patent/GB9806029D0/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AR016920A1 publication Critical patent/AR016920A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Uso de una 8a-azalida para la preparacion de un medicamento util para el tratamiento o prevencion de una infeccion entérica o respiratoria bacteriana, quecomprende una cantidad terapéutica o profilácticamente efectiva de dicha 8a-azalida y al menosu n vehículo apropiado.
ARP980104488A 1997-09-10 1998-09-09 FORMULACIoN DE 8A-AZALIDAS uTIL PARA EL TRATAMIENTO O PREVENCIoN DE UNA INFECCION ENTÉRICA O RESPIRATORIA BACTERIANA AR016920A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5832997P 1997-09-10 1997-09-10
GBGB9806029.6A GB9806029D0 (en) 1998-03-20 1998-03-20 8a-Azalides as veterinary antimicrobial agents

Publications (1)

Publication Number Publication Date
AR016920A1 true AR016920A1 (es) 2001-08-01

Family

ID=46203437

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104488A AR016920A1 (es) 1997-09-10 1998-09-09 FORMULACIoN DE 8A-AZALIDAS uTIL PARA EL TRATAMIENTO O PREVENCIoN DE UNA INFECCION ENTÉRICA O RESPIRATORIA BACTERIANA

Country Status (9)

Country Link
KR (1) KR100426510B1 (es)
AR (1) AR016920A1 (es)
BE (1) BE2012C011I2 (es)
BG (1) BG64765B1 (es)
CY (2) CY1112647T1 (es)
FR (1) FR12C0022I2 (es)
HR (1) HRP20000140A2 (es)
LU (1) LU91963I2 (es)
NO (1) NO312746B1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions

Also Published As

Publication number Publication date
FR12C0022I2 (fr) 2013-11-01
KR20010023822A (ko) 2001-03-26
BE2012C011I2 (en) 2018-02-05
NO20001231L (no) 2000-05-08
CY1112647T1 (el) 2016-02-10
FR12C0022I1 (es) 2012-04-27
CY2012008I1 (el) 2016-04-13
HRP20000140A2 (en) 2000-12-31
KR100426510B1 (ko) 2004-04-13
LU91963I2 (fr) 2012-05-29
NO20001231D0 (no) 2000-03-09
BG104235A (en) 2000-11-30
BG64765B1 (bg) 2006-03-31
NO312746B1 (no) 2002-07-01
CY2012008I2 (el) 2016-04-13
LU91963I9 (es) 2019-01-02

Similar Documents

Publication Publication Date Title
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
EE9700192A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
BR0111195A (pt) Uso de b-l-2'-desoxi-nucleosìdeos no tratamento de infecção por vìrus de hepatite delta
TR199903053T2 (xx) Benzimidazol t�revleri.
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
BR9811298A (pt) Uso de um composto de vanádio fisiologicamente aceitável
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
WO2000012049A3 (en) A method for the treatment of staphylococcal disease
WO1997018790A3 (en) Therapeutic and diagnostic agents for the treatment of microbial infections
NO990440L (no) Preparat som innbefatter mupirocin og klorheksidin
WO2000030435A3 (en) Foulbrood treatments
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
WO1999051256A3 (en) Use of l-glu-l-trp in the treatment of hiv infection
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
AP9400647A0 (en) Medicaments for use in treatment of HIV or cancer patients.
GB0028130D0 (en) Polypeptide and uses thereof
EE03514B1 (et) Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
AU3401093A (en) Therapeutic agent for threatened abortion
AR016920A1 (es) FORMULACIoN DE 8A-AZALIDAS uTIL PARA EL TRATAMIENTO O PREVENCIoN DE UNA INFECCION ENTÉRICA O RESPIRATORIA BACTERIANA
NZ512850A (en) Treatment of papillomavirus infections
PT1052991E (pt) Utilizacao de loperamida para o tratamento de infeccoes microbianas
MD980129A (en) Antiherpetic remedy

Legal Events

Date Code Title Description
FC Refusal